netFormulary
 Report : A-Z NHS England items in Formulary 18/09/2019 02:02:06
[Back]
 
Section Status NHS England Name
08.01.05 Formulary MHS England Alectinib 
08.01.05 Formulary MHS England Arsenic Trioxide Trisenox®
10.01.03 Restricted Use MHS England Avelumab Bavencio ®
08.02.04 Formulary MHS England Axicabtagene ciloleucel  YESCARTA®
03.14 Formulary MHS England Benralizumab 
08.01.05 Formulary MHS England Brigatinib Alunbrig®
08.01.05 Formulary MHS England Ceritinib  Zykadia®
08.01.03 Formulary MHS England Cytarabine–daunorubicin liposomal Vyxeos®
08.01.05 Formulary MHS England Dabrafenib with Trametinib 
08.01.05 Formulary MHS England Daratumumab Darzalex ®
08.02.03 Formulary MHS England Dinutuximab 
08.01.05 Formulary MHS England Durvalumab 
08.02.03 Formulary MHS England Gemtuzumab Mylotarg®
05.03.03.02 Formulary MHS England Glecaprevir–pibrentasvir Maviret®
08.01.05 Formulary MHS England Ibrutinib Imbruvica®
08.02.03 Formulary MHS England Inotuzumab ozogamicin Besponsa ®
08.01.05 Restricted Use MHS England Ixazomib 
08.01.05 Formulary MHS England Lenvatinib Kisplyx ®
08.03.04.03 Formulary MHS England Lutetium (177Lu) oxodotreotide 
03.14 Formulary MHS England Mepolizumab (Nucala®
08.01.05 Formulary MHS England Midostaurin  Rydapt®
08.01.05 Formulary MHS England Niraparib 
08.01.05 Formulary MHS England Niraparib 
08.02.03 Formulary MHS England Ocrelizumab 
03.11 Restricted Use MHS England Pirfenidone Esbriet®
05.03.03.02 Formulary MHS England Sofosbuvir-velpatasvir-voxilaprevir 
09.05.02.02 Formulary MHS England Sucroferric oxyhydroxide Velphoro®
08.01.05 Formulary MHS England Tisagenlecleucel Kymriah®
08.01.05 Formulary MHS England Tivozanib Fotivda®
Birmingham, Sandwell, Solihull and environs APC Formulary